Clinical and Dosimetric Variables Related to Outcome After Treatment of Graves' Disease With 550 and 1110 MBq of 131I: Results of a Prospective Randomized Trial (2015)
- Authors:
- USP affiliated authors: SAPIENZA, MARCELO TATIT - FM ; BUCHPIGUEL, CARLOS ALBERTO - FM ; WATANABE, TOMOCO - FM
- Unidade: FM
- DOI: 10.1097/RLU.0000000000000840
- Subjects: DOSIMETRIA; IODO; MEDICINA NUCLEAR (TRATAMENTO); DOENÇA DE GRAVES; GLÂNDULA TIREOIDE; HIPERTIREOIDISMO
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2015
- Source:
- Título: Clinical Nuclear Medicine
- ISSN: 0363-9762
- Volume/Número/Paginação/Ano: v. 40, n. 9, p. 715-719, 2015
- Este artigo NÃO possui versão em acesso aberto
-
Status: Nenhuma versão em acesso aberto identificada -
ABNT
SAPIENZA, Marcelo Tatit et al. Clinical and Dosimetric Variables Related to Outcome After Treatment of Graves' Disease With 550 and 1110 MBq of 131I: Results of a Prospective Randomized Trial. Clinical Nuclear Medicine, v. 40, n. 9, p. 715-719, 2015Tradução . . Disponível em: https://doi.org/10.1097/RLU.0000000000000840. Acesso em: 14 mar. 2026. -
APA
Sapienza, M. T., Coura-Filho, G. B., Willegaignon, J., Watanabe, T., Duarte, P. S., & Buchpiguel, C. A. (2015). Clinical and Dosimetric Variables Related to Outcome After Treatment of Graves' Disease With 550 and 1110 MBq of 131I: Results of a Prospective Randomized Trial. Clinical Nuclear Medicine, 40( 9), 715-719. doi:10.1097/RLU.0000000000000840 -
NLM
Sapienza MT, Coura-Filho GB, Willegaignon J, Watanabe T, Duarte PS, Buchpiguel CA. Clinical and Dosimetric Variables Related to Outcome After Treatment of Graves' Disease With 550 and 1110 MBq of 131I: Results of a Prospective Randomized Trial [Internet]. Clinical Nuclear Medicine. 2015 ; 40( 9): 715-719.[citado 2026 mar. 14 ] Available from: https://doi.org/10.1097/RLU.0000000000000840 -
Vancouver
Sapienza MT, Coura-Filho GB, Willegaignon J, Watanabe T, Duarte PS, Buchpiguel CA. Clinical and Dosimetric Variables Related to Outcome After Treatment of Graves' Disease With 550 and 1110 MBq of 131I: Results of a Prospective Randomized Trial [Internet]. Clinical Nuclear Medicine. 2015 ; 40( 9): 715-719.[citado 2026 mar. 14 ] Available from: https://doi.org/10.1097/RLU.0000000000000840 - Visualization of Lymph Nodal and Hepatic Metastases of Medullary Thyroid Carcinoma on 18F-Fluoride PET/CT
- Pediatric 131I-MIBG therapy for neuroblastoma: whole-Body 131I-MIBG clearance, radiation doses to patients, family caregivers, medical staff, and radiation safety measures
- Bone and Calcified Soft Tissue Metastases of Medullary Thyroid Carcinoma Better Characterized on F-18-Fluoride PET/CT than on Ga-68-Dotatate PET/CT
- Brain metastasis of medullary thyroid carcinoma without macroscopic calcification detected first on 68Ga-Dotatate and then on 18F-Fluoride PET/CT
- Iodine/FDG ""Flip-Flop"" phenomenon inside a large metastatic thyroid cancer lesion better characterized on SPECT/CT and PET/CT studies [Editorial]
- Estudos diagnósticos com análogos da somatostatina
- Foreign body perforating the descending colon incidentally Detected on 'ANTPOT. 18 F'-DG PET/CT
- PET/CT no câncer de esôfago
- Accuracy in dosimetry of diagnostic agents: impact of the number of source tissues used in whole organ S value-based calculations
- Comparative dosimetry for Ga-68-DOTATATE: impact of using updated ICRP phantoms, S values, and tissue-weighting factors
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
